Stocks · Health care · Services-Medical Laboratories

GRAIL, Inc.

GRAL Clue Score54
United States Fiscal year ends December CIK 0001699031 Results filed 4 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Joshua J. Ofman
15 Oct 2026
Chief Executive Officer
Sold on a plan
2,114
$138.79
$293.39K
Joshua J. Ofman
15 Oct 2026
Chief Executive Officer
Sold on a plan
6,034
$137.63
$830.47K
Joshua J. Ofman
15 Oct 2026
Chief Executive Officer
Sold on a plan
7,052
$136.83
$964.95K
Joshua J. Ofman
15 Oct 2026
Chief Executive Officer
Sold on a plan
3,400
$135.44
$460.51K
Joshua J. Ofman
15 Oct 2026
Chief Executive Officer
Sold on a plan
1,000
$134.38
$134.38K
Joshua J. Ofman
15 Oct 2026
Chief Executive Officer
Sold on a plan
400
$133.12
$53.25K

What was left out

Form 4 filings counted 6
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 538
History held since 24 Jun 2024